Harmine Derivative H‐2‐104 Alleviates Echinococcus granulosus ‐Induced Pulmonary Fibrosis in Mice by Inhibiting Fibroblast Activation and Inducing DNA Damage
Journal of Immunology Research · 2026
DOI: 10.1155/jimr/8865338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2026. Verfasst von Yuehong Gong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Xinjiang Medical University, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang, China, x…. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, DNA Damage, Echinococcus granulosus, Fibroblasts. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Tianshan Talents" High-Level Medical and Health Personnel Training Plan of the Health Commission of Xinjiang Uygur Autonomous Region, Xinjiang Uyghur Autonomous Region College Students Innovation Training Program Project.
Abstract (Originalsprache)
Background
Pulmonary fibrosis (PF) secondary to Echinococcus granulosus infection is a severe complication with limited therapeutic options. Harmine (HM) exhibits antifibrotic potential but is restricted by significant neurotoxicity. This study aimed to evaluate the therapeutic efficacy and underlying mechanism of HM derivative H‐2‐104 in a clinically relevant E. granulosus ‐induced PF mouse model, and to clarify its advantages over parent compound HM.
Methods
A mouse model of E. granulosus ‐induced PF was established, and treated with H‐2‐104 (25 or 50 mg/kg) or nintedanib for 21 days. Lung function, histopathology, hydroxyproline (HYP), inflammatory cytokines, and fibrosis‐related protein expression were assessed. In vitro, human embryonic lung fibroblasts (MRC‐5) were activated with TGF‐β1 and treated with H‐2‐104. Cell viability, migration, apoptosis, differentiation, DNA damage, and related gene expression were evaluated.
Results
H‐2‐104 significantly improved lung function, alleviated pathological damage, and collagen deposition, decreased HYP, TGF‐β1, TNF‐α, IL‐6, and IL‐1β, elevated IL‐10, and downregulated α‐smooth muscle actin (α‐SMA), collagen I, and fibronectin. Importantly, H‐2‐104 showed no obvious neurotoxicity and exhibited better safety than HM. In vitro, H‐2‐104 inhibited TGF‐β1‐induced MRC‐5 cell viability (IC 50 = 13.49 µg/mL), migration, and fibroblast‐to‐myofibroblast differentiation, while promoting apoptosis along with increased DNA damage in a dose‐dependent manner. Additionally, H‐2‐104 downregulated the expression of fibrosis‐related genes and upregulated DNA damage‐related genes ( H2AX , ATR , and RAD51 ) in TGF‐β1‐induced MRC‐5 cells.
Conclusion
This study establishes H‐2‐104 as a promising antifibrotic candidate for E. granulosus ‐induced PF, using a clinically meaningful parasitic infection‐associated fibrosis model. H‐2‐104 retains strong antifibrotic efficacy while overcoming the neurotoxicity limitation of HM. Mechanistically, the activation of DNA damage response is correlated with the antifibrotic activities of H‐2‐104, providing a new perspective for targeting fibroblast activation in PF therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy, Xinjiang Medical University, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang, China, xjmu.edu.cn.
- Department of Pharmacy, Xinjiang Key Laboratory of Clinical Drug Research, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang, China, xjmu.edu.cn.
- College of Pharmacy, Xinjiang Medical University, Urumqi 830017, Xinjiang, China, xjmu.edu.cn.
- School of Clinical Medicine, Xinjiang Medical University, Urumqi 830017, Xinjiang, China, xjmu.edu.cn.
ORCID-Profile: Haibo Zhang, Junping Hu
Förderung
- "Tianshan Talents" High-Level Medical and Health Personnel Training Plan of the Health Commission of Xinjiang Uygur Autonomous Region
- Xinjiang Uyghur Autonomous Region College Students Innovation Training Program Project
Zitieren
APA
Gong, Y., Cui, Y., Pan, M., Zhang, H., Abudusaimaiti, Y., Tang, G., Ren, H., Fu, L., Yang, J., & Hu, J. (2026). Harmine Derivative H‐2‐104 Alleviates Echinococcus granulosus ‐Induced Pulmonary Fibrosis in Mice by Inhibiting Fibroblast Activation and Inducing DNA Damage. Journal of Immunology Research. https://doi.org/10.1155/jimr/8865338
Vancouver
Gong Y, Cui Y, Pan M, Zhang H, Abudusaimaiti Y, Tang G, et al. Harmine Derivative H‐2‐104 Alleviates Echinococcus granulosus ‐Induced Pulmonary Fibrosis in Mice by Inhibiting Fibroblast Activation and Inducing DNA Damage. Journal of Immunology Research. 2026. doi:10.1155/jimr/8865338
BibTeX
@article{Gong2026,
author = {Gong, Yuehong and Cui, Yating and Pan, Miechi and Zhang, Haibo and Abudusaimaiti, Yisikandier and Tang, Guohua and Ren, Hang and Fu, Lijie and Yang, Jianhua and Hu, Junping},
title = {Harmine Derivative H‐2‐104 Alleviates Echinococcus granulosus ‐Induced Pulmonary Fibrosis in Mice by Inhibiting Fibroblast Activation and Inducing DNA Damage},
journal = {Journal of Immunology Research},
year = {2026},
doi = {10.1155/jimr/8865338}
}
EUVIMED